Feeds

Lab mice deaths cast doubt over RNAi

Setback for powerful therapy?

Beginner's guide to SSL certificates

A technology that has been lauded as a panacea for many currently incurable diseases has been dealt a blow by researchers. A paper appearing in Nature says mice given RNA interference therapy (RNAi) died of liver failure and other complications.

RNA is a close chemical relative of DNA. While DNA can be thought of as an unchanging leather-bound archive, RNA molecules are more like newspapers – dynamic, throwaway and with different agendas. RNA is the workhorse of biological information.

The principle behind RNAi is to use short double-stranded tracts of RNA as guided missiles, intercepting longer RNA messages which pass on information from DNA, before they can be used to make functioning proteins. It's thought to have developed early in evolution - bacteria use it too - as a means of combating viral infections.

Teams are working on harnessing its power to treat both deadly inherited conditions like Huntington's and infectious disease, such as HIV.

For this latest study, a team at Stanford medical school exposed mice to long-term high doses of RNAi. They tried out 49 different RNAi therapies designed to shut down six different genes in liver cells. 36 of the snippets caused liver injury, and 23 led to death within two months.

For biotech firms pumping millions into the field, the news may bring concerning echoes problems researchers have had fulfilling the potential of similarly promising gene therapy technology, which gave patients cancer in an early trial. Proponents say the study should act as a warning, but does not signal disaster for RNAi.

The Stanford team used an indirect approach to introduce the RNAi – they forced the mice's own cells to build them. The scientists speculate that this may have overloaded the cellular machinery, leading to the liver damage and deaths.

John Maraganore of biotech firm Alnylam Pharmaceuticals, which says it has already safely tested a respitory infection RNAi nasal spray told the NYT: "These data really represent the fundamental limitations of gene therapy, not of RNAi."

The authors of the study also note, despite the mouse deaths, other work they did proving the ability of RNAi to silence errant genes "fuels hope" of a whole new mode of attack against illness. ®

Internet Security Threat Report 2014

More from The Register

next story
GRAV WAVE DRAMA: 'Big Bang echo' may have been grit on the scanner – boffins
Exit Planet Dust on faster-than-light expansion of universe
SpaceX Dragon cargo truck flies 3D printer to ISS: Clawdown in 3, 2...
Craft berths at space station with supplies, experiments, toys
That glass of water you just drank? It was OLDER than the SUN
One MEELLION years older. Some of it anyway
Big dinosaur wowed females with its ENORMOUS HOOTER
That's right, Doris, I've got biggest snout in the prehistoric world
Japanese volcano eruption reportedly leaves 31 people presumed dead
Hopes fade of finding survivors on Mount Ontake
Relive the death of Earth over and over again in Extinction Game
Apocalypse now, and tomorrow, and the next day, and the day after that ...
prev story

Whitepapers

Providing a secure and efficient Helpdesk
A single remote control platform for user support is be key to providing an efficient helpdesk. Retain full control over the way in which screen and keystroke data is transmitted.
Intelligent flash storage arrays
Tegile Intelligent Storage Arrays with IntelliFlash helps IT boost storage utilization and effciency while delivering unmatched storage savings and performance.
Beginner's guide to SSL certificates
De-mystify the technology involved and give you the information you need to make the best decision when considering your online security options.
Security for virtualized datacentres
Legacy security solutions are inefficient due to the architectural differences between physical and virtual environments.
Secure remote control for conventional and virtual desktops
Balancing user privacy and privileged access, in accordance with compliance frameworks and legislation. Evaluating any potential remote control choice.